Switzerland offers one of the world’s most advanced environments for biotechnology and life science innovation. The country combines scientific excellence, strong regulatory standards and a long tradition of precision engineering and industrial fermentation.
TwentyGreen benefits from this ecosystem through close collaboration with leading research institutions including EPFL and the University of Bern, as well as access to Switzerland’s highly specialized life science infrastructure.
Switzerland is home to globally recognized pharmaceutical and biotechnology companies, as well as a strong network of academic laboratories, startups and research institutes working at the forefront of microbiome science.
This environment enables TwentyGreen to develop advanced bioprocess technologies for the cultivation of beneficial human gut archaea while maintaining the highest standards of scientific rigor, safety and product quality.
By combining Swiss scientific excellence with cutting-edge microbiome research, TwentyGreen contributes to the development of next-generation microbiome technologies for research, therapeutics and precision health.
